SEC Form 4/A · accession 0001493152-26-033818
Eton Pharmaceuticals, Inc. · ETON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Opaleye Management Inc.
10% Owner
Period of report
Jul 14, 2026
Accepted (ET)
Jul 17, 2026 · 7:12 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001710340
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per shareF3,F1,F4 | Jul 14, 2026 | S | 15,000 | $37.5431 | D | 2,665,000 | I | By Opaleye, L.P. |
| Common Stock, par value $0.001 per shareF3,F2,F4 | Jul 14, 2026 | S | 13,315 | $37.5431 | D | 40,000 | I | By Managed Account |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management, Inc. may be deemed to beneficially own the securities owned directly by the Fund.
- F2Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye Management, Inc. may be deemed to beneficially own the securities owned directly by the Managed Account.
- F3The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.0152 to $37.9148 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
- F4Opaleye Management, Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management, Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Remarks
This amendment is filed solely to check the box indicating that the reporting person is no longer subject to Section 16.